SPRI | Novel Therapeutics For Rare Lymphomas (2020 EN)

Discussion in 'Medicine' started by Kanka, May 3, 2020.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Christopher Dittus (Editor)
    Full Title: Novel Therapeutics For Rare Lymphomas
    Publisher: Springer; 1st ed. 2020 edition (December 9, 2019)
    Year: 2020
    ISBN-13: 9783030256104 (978-3-030-25610-4), 9783030256098 (978-3-030-25609-8)
    ISBN-10: 3030256103, 303025609X
    Pages: 253
    Language: English
    Genre: Medicine: Oncology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 124.79 €


    This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

    -------------